| ID Source | ID |
|---|---|
| PubMed CID | 65725 |
| CHEBI ID | 173320 |
| SCHEMBL ID | 1163805 |
| MeSH ID | M0040260 |
| Synonym |
|---|
| CHEBI:173320 |
| nsc196570 |
| nsc-196570 |
| nsc38250 |
| nsc-38250 |
| 3-aminooxazolidin-2-one |
| 2-oxazolidinone, 3-amino- |
| 3-amino-2-oxazolidone |
| nsc111187 |
| 80-65-9 |
| 3-amino-2-oxazolidinone |
| nsc-111187 |
| 3-amino-1,3-oxazolidin-2-one |
| inchi=1/c3h6n2o2/c4-5-1-2-7-3(5)6/h1-2,4h |
| FT-0661968 |
| A839960 |
| 3-aminooxazolidin-2-id-4-one |
| einecs 201-299-2 |
| nsc 111187 |
| unii-vj7he86a15 |
| vj7he86a15 , |
| AKOS006228286 |
| aoz , |
| FT-0614939 |
| S10190 |
| 3-amino oxazolidinone |
| SCHEMBL1163805 |
| DTXSID00229996 |
| 3-amino-1,3-oxazolidin-2-one # |
| AC-33916 |
| F9995-4179 |
| aoz, vetranal(tm), analytical standard |
| AS-57894 |
| 3-amino-2-oxazolidinone (aoz) |
| 3-amino-2-oxazolidinone aoz |
| mfcd00020871 |
| BCP32566 |
| CS-W013698 |
| 2-oxazolidinone, 3-amino-;3-amino-1,3-oxazolidin-2-one;3-aminooxazolidin-2-one |
| SY038618 |
| A936035 |
| HY-W012982 |
| EN300-115889 |
| 3-amino-2-oxazolidinone (aoz) 100 microg/ml in acetonitrile |
| Z1198147716 |
| 1ST4201 |
| Class | Description |
|---|---|
| oxazolidinone | An oxazolidine containing one or more oxo groups. |
| [compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] | |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 9 (25.00) | 18.7374 |
| 1990's | 4 (11.11) | 18.2507 |
| 2000's | 10 (27.78) | 29.6817 |
| 2010's | 11 (30.56) | 24.3611 |
| 2020's | 2 (5.56) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 45 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
| Article | Year |
|---|---|
| Tissue depletion and concentration correlations between edible tissues and biological fluids of 3-amino-2-oxazolidinone in pigs fed with a furazolidone-medicated feed. Journal of agricultural and food chemistry, Jun-09, Volume: 58, Issue: 11 | 2010 |
| [information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | |